A new life science campus has been approved to start construction in the UK.
According to a release, UBS Asset Management and the Reef Group, a UK-based developer of life science facilities, have gotten approval to start construction on a new £900 million ($1.1 billion) life sciences hub at the Stevenage Bioscience Catalyst. The new site is also inside the “golden triangle,” which is described as the area between the biotech and research hubs of London, Cambridge and Oxford. This facility is set to be built alongside GSK’s existing global R&D facility in the catalyst.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.